Skip to main content
Login
Contact
Subscribe
Search form
Search
The Daily Press
Home
Forms
News
Sports
Classifieds
Place a Classified Ad
Classified Display Ads
Obituaries
Entertainment
Special Sections
Talking About...
Photos
Videos
Games
Community Links
St. Mary's Chamber
Elk County Sheriff
St. Mary's Area School District
Elk County Catholic School System
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Strongbridge Bio Ord
(NQ:
SBBP
)
4.350
USD
UNCHANGED
Official Closing Price
/ Updated:
4:00 PM EDT, Sep 21, 2018
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
378,700
Open
4.400
Bid (Size)
3.600 (169)
Ask (Size)
6.400 (4)
Prev. Close
4.350
Today's Range
4.230 - 4.600
52wk Range
3.850 - 9.250
Shares Outstanding
35,335,026
Dividend Yield
N/A
Performance
YTD
-42.38%
-42.38%
1 Month
-19.44%
-19.44%
3 Month
-29.84%
-29.84%
6 Month
-45.96%
-45.96%
1 Year
-41.22%
-41.22%
Top News
More News
Strongbridge Biopharma plc to Participate in Two Upcoming Healthcare Investor Conferences
September 18, 2018
Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet...
Read More
from
GlobeNewswire News Releases
Strongbridge Biopharma plc Announces Presentations at Two Upcoming Investor Conferences
August 28, 2018
Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet...
Read More
from
GlobeNewswire News Releases
More News
Read More
Strongbridge Biopharma plc Announces New Employment Inducement Awards
August 28, 2018
from
GlobeNewswire News Releases
Strongbridge Biopharma plc Announces Termination of Public Offering of Ordinary Shares
August 15, 2018
from
GlobeNewswire News Releases
Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares
August 14, 2018
from
GlobeNewswire News Releases
Aeterna Zentaris Reports Second Quarter 2018 Financial and Operating Results
August 09, 2018
from
GlobeNewswire News Releases
Analysts Expect 20% Gains Ahead For IBB
September 06, 2018
category
ETFs
from
ETF Channel
Morning Call For Wednesday, August 15
August 15, 2018
category
Bonds
,
Stocks / Equities
,
Commodities
, and 1 more.
from
Blogs - TalkMarkets
The 3 Hottest Insider Trading Stocks Right Now
August 14, 2018
category
Stocks / Equities
from
Blogs - TalkMarkets
3 Biotech Stocks That Soared This Week: Are They Buys?
August 11, 2018
category
ZIOP
,
Market News
,
ENDP
, and 1 more.
from
Motley Fool
Here's Why Strongbridge Biopharma Rose as Much as 26.7% Today
August 08, 2018
category
SBBP
,
Market News
from
Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
